Is high serum programmed death ligand 1 level a risk factor for poor survival in patients with gastric cancer?

BACKGROUND AND AIM: Although the clinicopathological significance of the expression of programmed death ligand 1(PD‐L1) in various cancer tissues has been reported, serum PD‐L1 level has not been evaluated in patients with surgically treated gastric cancer. Therefore, we evaluated the clinicopatholo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Masaaki, Oshima, Yoko, Yajima, Satoshi, Suzuki, Takashi, Nanami, Tatsuki, Shiratori, Fumiaki, Funahashi, Kimihiko, Nemoto, Tetsuo, Shimada, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036390/
https://www.ncbi.nlm.nih.gov/pubmed/30003194
http://dx.doi.org/10.1002/ags3.12175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036390/
https://www.ncbi.nlm.nih.gov/pubmed/30003194
http://dx.doi.org/10.1002/ags3.12175

Ejemplares similares